The challenges and experiences of New Graduate Registered Nurses (NGRNs) during the Covid-19 pandemic: An integrative review.

Publication date: Aug 01, 2025

This study aimed to attain a comprehensive understanding of the challenges and experiences of New Graduate Registered Nurses (NGRNs) who cared for patients with COVID-19 during the COVID-19 pandemic. During the COVID-19 pandemic, NGRNs quickly adapted to demanding clinical roles, showing resilience, initiative, and commitment to growth. Through mentorship and teamwork, they developed stronger professional identities. These experiences, though crisis-driven, underscore the lasting value of flexible training, emotional support, and structured transitions in all healthcare settings. An integrative review method by Whittemore and Knafl (2005). An initial pool of 836 records was identified, with 22 articles meeting the criteria for review. From these, four main themes and ten subthemes emerged: Pandemic-Specific Conditions Faced by NGRNs – educational/training conditions, working conditions, and physical/psychological conditions; Pandemic-Related Concerns Raised by NGRNs -proficiency/experience concerns and safety concerns; Pandemic-Related Positive Responses by NGRNs – proactivity, staying positive, and advocating for nurses; Pandemic-Related Growth Among NGRNs -professional and personal development and pandemic-fostered commitment and advocacy. The experiences of NGRNs during the pandemic revealed their capacity for resilience, adaptability, and leadership under pressure. Each theme-ranging from proactive learning to advocacy and professional growth-highlights both the challenges faced, and the strengths developed. These insights extend beyond crisis response, offering practical guidance for building supportive, flexible, and future-ready systems that empower NGRNs in both pandemic and non-pandemic healthcare settings.

Concepts Keywords
Future COVID-19
Nurses Female
Pandemic Humans
Pool Pandemics
Teamwork SARS-CoV-2

Semantics

Type Source Name
disease MESH Covid-19 pandemic
drug DRUGBANK Pentaerythritol tetranitrate

Original Article

(Visited 1 times, 1 visits today)